Safety and efficacy of allogeneic stem cell transplantation after nivolumab therapy for patients with relapsed/refractory classical Hodgkin lymphoma

被引:0
|
作者
Beynarovich, A. [1 ]
Lepik, K. [2 ]
Mikhailova, N. [3 ]
Kondakova, E. [2 ]
Zalyalov, Y. [2 ]
Moiseev, I. [2 ]
Afanasyev, B. [2 ]
机构
[1] Pavlov First St Petersburg State Med Univ, Raisa Gorbacheva Mem Res Inst Children Oncol Hema, St Petersburg, Russia
[2] Raisa Gorbacheva Mem Res Inst Children Oncol Hema, Hematol, St Petersburg, Russia
[3] Sci Res Inst Pediat Oncol Hematol & Transplantol, Raisa Gorbacheva Mem Res Inst Children Oncol Hema, St Petersburg, Russia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
62P
引用
收藏
页码:22 / +
页数:2
相关论文
共 50 条
  • [21] Allogeneic stem cell transplantation for relapsed or refractory Hodgkin lymphoma: a better therapeutical perspective
    Greco, M. M.
    Carella, A. M.
    Merla, E.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S288 - S289
  • [22] A Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma
    Perales, Miguel -Angel
    Cho, Christina
    Eaton, Anne
    Moskowitz, Alison J.
    Nguyen, Victoria
    Conzales-Dadiz, Anne Marie R.
    Devlin, Sean
    Giralt, Sergio A.
    Jakubowski, Ann A.
    Matasar, Matthew J.
    Noy, Ariela
    Portlock, Carol S.
    Straus, David J.
    Young, James W.
    Barker, Juliet N.
    Moskowitz, Craig H.
    BLOOD, 2015, 126 (23)
  • [23] Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma
    Ge, Shiliang
    Lepic, Kylie
    Bhindi, Ravi
    Berg, Tobias
    Khalaf, Dina
    Leber, Brian
    Radford, Michael
    Walker, Irwin
    Davies, Gwynivere
    Garcia-Horton, Alejandro
    CURRENT ONCOLOGY, 2025, 32 (02)
  • [24] Nivolumab after allogeneic hematopoietic stem cell transplantation in relapsed/refractory hodgkin's lymphoma (RR-HL) - A single center experience
    Moreira, A.
    Viegas, D.
    Teixeira, G.
    Ferreira, I.
    Miranda, N.
    Moita, F.
    Jorge, A. S.
    Gutierrez, M. J.
    Leal da Costa, F.
    Abecasis, M.
    BONE MARROW TRANSPLANTATION, 2019, 54 : 468 - 469
  • [25] Allogeneic hematopoietic stem cell transplantation outcomes after nivolumab monotherapy for plus relapsed/refractory hodgkin lymphoma (CheckMate 039 and CheckMate 205)
    Carlo-Stella, C.
    Collins, G.
    Armand, P.
    Zinzani, P. L.
    Cohen, J. B.
    Halwani, A.
    Millenson, M.
    Provencio, M.
    Domingo Domenech, E.
    Giulino-Roth, L.
    Castagna, L.
    Kato, K.
    McKiver, M. Popa
    Sumbul, A.
    Zhu, L.
    Trneny, M.
    Minnema, M. C.
    Rueda, A.
    Cunningham, D.
    Reddy, N.
    Younes, A.
    Santoro, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S15 - S16
  • [26] Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
    Liudmila V. Fedorova
    Kirill V. Lepik
    Nikita P. Volkov
    Polina V. Kotselyabina
    Evgenia S. Borzenkova
    Marina O. Popova
    Anastasia V. Beynarovich
    Vadim V. Baykov
    Andrey V. Kozlov
    Ivan S. Moiseev
    Natalia B. Mikhailova
    Alexander D. Kulagin
    International Journal of Clinical Oncology, 2022, 27 : 626 - 632
  • [27] Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
    Fedorova, Liudmila, V
    Lepik, Kirill, V
    Volkov, Nikita P.
    Kotselyabina, Polina, V
    Borzenkova, Evgenia S.
    Popova, Marina O.
    Beynarovich, Anastasia, V
    Baykov, Vadim V.
    Kozlov, Andrey, V
    Moiseev, Ivan S.
    Mikhailova, Natalia B.
    Kulagin, Alexander D.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (03) : 626 - 632
  • [28] Brentuximab vedotin for relapse or progression therapy after allogeneic hematopoietic stem cell transplantation in relapsed / refractory classic Hodgkin lymphoma
    Mikhailova, N.
    Popova, M.
    Kondakova, E.
    Ivanova, M.
    Borzenkova, E.
    Alaynskiy, A.
    Bondarenko, S.
    Afanasyev, B.
    Babenko, E.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S503 - S503
  • [29] Successful treatment with low-dose nivolumab in refractory Hodgkin lymphoma after allogeneic stem cell transplantation
    Makoto Onizuka
    Minoru Kojima
    Keiko Matsui
    Shinichiro Machida
    Masako Toyosaki
    Yasuyuki Aoyama
    Hidetsugu Kawai
    Jun Amaki
    Ryujiro Hara
    Akifumi Ichiki
    Yoshiaki Ogawa
    Hiroshi Kawada
    Naoya Nakamura
    Kiyoshi Ando
    International Journal of Hematology, 2017, 106 : 141 - 145
  • [30] Successful treatment with low-dose nivolumab in refractory Hodgkin lymphoma after allogeneic stem cell transplantation
    Onizuka, Makoto
    Kojima, Minoru
    Matsui, Keiko
    Machida, Shinichiro
    Toyosaki, Masako
    Aoyama, Yasuyuki
    Kawai, Hidetsugu
    Amaki, Jun
    Hara, Ryujiro
    Ichiki, Akifumi
    Ogawa, Yoshiaki
    Kawada, Hiroshi
    Nakamura, Naoya
    Ando, Kiyoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (01) : 141 - 145